Bcbs Of Mi Page

BCBSM reported a $246 million loss in 2025 on $43.3 billion in revenue. While still negative, this reflects improved stability compared to prior years, driven by a cost-cutting program that eliminated $420 million in administrative and reimbursement costs over three years.

BCBSM has moved to restrict coverage for popular GLP-1 weight-loss medications like Zepbound, Wegovy, and Saxenda for most commercial fully insured groups. bcbs of mi

Recent member reviews highlight significant frustrations with high monthly premiums and deductibles. Common complaints include difficult customer service interactions and claims denials. BCBSM reported a $246 million loss in 2025 on $43